Floatz logo

NEPENTHE

Intracerebral Hemorrhage

Henry M. Jackson Foundation for the Advancement of Military MedicineSmall moleculePhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
81/ 100

Competitive context

23 Active assets in the Intracerebral Hemorrhage cohort.

Asset / SponsorPhaseRating
Rivaroxaban
Imperial College London
Phase 3B
Dabigatran
Imperial College London
Phase 3B
Apixaban
Region Stockholm
Phase 3B
Cerebrolysin
Cardinal Stefan Wyszynski University
Phase 4B
PROPRANOLOL
Tang-Du Hospital
Phase 2/3B

View all 42 →

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →